Veeco Instruments Targets $1B Revenue on AI Photonics Demand

Veeco Instruments (NASDAQ: VECO) is positioning its core deposition and etching technologies to capture a projected $2 billion expansion in the indium phosphide laser manufacturing market. The company’s strategy centers on the transition from copper interconnects to co-packaged optics in AI data centers, a shift that requires the high-precision optical films produced by Veeco’s Spectre Ion Beam Deposition (IBD) systems. Management confirmed over $250 million in new orders for MOCVD, wet processing, and IBD tools, with deliveries slated to begin in the third quarter of 2026 and accelerate significantly into 2027.

The Transmission Path: AI Data Center Infrastructure

The fundamental driver for Veeco is the industry-wide move toward higher bandwidth density and improved power efficiency in AI optical infrastructure. As data centers scale, the reliance on indium phosphide lasers for next-generation 800-gig and 1.6-terabyte optical transceivers creates a direct tailwind for Veeco’s product suite. The company’s Spectre IBD system is currently the primary tool for laser facet coating, a critical step where traditional PVD or E-beam evaporation methods fail to meet the required reflectivity and thickness uniformity. By leveraging its incumbent position in laser facet coating and expanding its footprint in epitaxy, Veeco is effectively tethering its revenue growth to the capital expenditure cycles of hyperscale data center operators.

Financial Mechanics and Revenue Headwinds

Veeco reported first-quarter revenue of $158 million, falling slightly short of guidance due to an $8 million impact from export license requirements for a mature node customer in China. This regulatory friction highlights the execution risk inherent in the company’s China-exposed business, which has seen a steady decline. However, management expects this headwind to be offset by mid-teens growth in the broader semiconductor segment, driven by laser annealing and advanced packaging. The company’s gross margin of 36% for the quarter was also pressured by this product mix, though guidance for the second quarter anticipates a recovery to between 38% and 40% as high-margin tool deployments ramp up.

Capacity Expansion and Execution Risks

To meet the projected demand, Veeco is undergoing a significant capacity expansion, targeting a 10x increase in Spectre IBD output by early 2027. The company is also exploring contract manufacturing partnerships in Southeast Asia to scale its wet processing technologies. These capital-intensive moves are necessary to support the $250 million order backlog, but they introduce operational complexity. Investors should monitor the progress of ongoing evaluations for the Propel 300 system in the gallium nitride (GaN) power market, which serves as a secondary growth vector for AI power efficiency. The success of these evaluations, expected to conclude by late 2026, will determine the company’s ability to capture additional market share in 300mm GaN-on-silicon production.

Valuation and Forward-Looking Catalysts

Veeco has reaffirmed its full-year 2026 revenue guidance of $740 million to $800 million, with non-GAAP EPS projected between $1.50 and $1.85. The company’s market analysis suggests that while the semiconductor business faces mature node headwinds, the compound semiconductor segment is expected to grow by approximately 50% on a WFE-equivalent basis. The next concrete marker for investors is the Q3 2026 delivery start date for the $250 million order block. Any delay in the engineering improvements required for the Spectre IBD system to meet high-volume front-end requirements would weaken the current growth thesis. Conversely, successful pilot line orders for the Propel 300 system in the second half of 2026 would provide a clear signal of sustained momentum in the GaN power sector.

With an Alpha Score of 66/100, NVDA remains a key proxy for the broader AI infrastructure demand that Veeco is currently servicing, while WELL provides a different look at real estate-linked growth. Veeco’s ability to maintain its lead in ion beam deposition while scaling its epitaxy business will be the primary determinant of whether it reaches its $1 billion revenue target by 2030.